Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Camurus AB (CAMRF)
OTHER OTC:CAMRF
Holding CAMRF?
Track your performance easily
CAMRF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$21.81 - $73.25
Previous Close$51.05
Volume2.00
Average Volume (3M)100.00
Market Cap
$3.00B
Enterprise Value$2.95B
Total Cash (Recent Filing)kr565.54M
Total Debt (Recent Filing)kr26.22M
Price to Earnings (P/E)116.8
Beta0.81
Next Earnings
Feb 13, 2025EPS Estimate
$0.16Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.44
Shares OutstandingN/A
10 Day Avg. Volume0
30 Day Avg. Volume100
Standard Deviation0.30
R-Squared0.20
Alpha0.07
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)13.62
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$67.71Price Target Upside32.86% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Camurus AB News
PremiumCompany Announcements
Camurus AB Reports Strong Q3 Results and Raises Outlook
PremiumPre-Earnings
Is CAMRF a Buy, Before Earnings?Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
2.66% Mutual Funds
― Other Institutional Investors
95.00% Public Companies and
Individual Investors
CAMRF FAQ
What was Camurus AB’s price range in the past 12 months?
Camurus AB lowest stock price was $21.81 and its highest was $73.25 in the past 12 months.
What is Camurus AB’s market cap?
Currently, no data Available
When is Camurus AB’s upcoming earnings report date?
Camurus AB’s upcoming earnings report date is Feb 13, 2025 which is in 48 days.
How were Camurus AB’s earnings last quarter?
Camurus AB released its earnings results on Nov 07, 2024. The company reported $0.194 earnings per share for the quarter, beating the consensus estimate of $0.141 by $0.054.
Is Camurus AB overvalued?
According to Wall Street analysts Camurus AB’s price is currently Undervalued.
Does Camurus AB pay dividends?
Camurus AB does not currently pay dividends.
What is Camurus AB’s EPS estimate?
Camurus AB’s EPS estimate is $0.16.
How many shares outstanding does Camurus AB have?
Camurus AB has 58,808,770 shares outstanding.
What happened to Camurus AB’s price movement after its last earnings report?
Camurus AB reported an EPS of $0.194 in its last earnings report, beating expectations of $0.141. Following the earnings report the stock price went up 4.991%.
Which hedge fund is a major shareholder of Camurus AB?
Currently, no hedge funds are holding shares in CAMRF
---
Company Description
Camurus AB
Camurus AB is a research and development focused pharmaceutical company. It develops pharmaceuticals for the treatment of serious and chronic diseases such as opioid addiction, pain, cancer and endocrine diseases. The company has Europe, North America and Other geographical areas geographic segments. It derives the majority of its revenues from North America geographic segment. The company's product pipeline includes CAM2038, CAM2029, CAM2032 product candidates.
---
CAMRF Company Deck
---
CAMRF Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented strong financial performance and growth in key product sales, along with a solid cash position. However, challenges such as the FDA's CRL and increased operating expenses were noted. The positive aspects of growth and profitability were more pronounced, leading to an optimistic outlook.Read More>---
CAMRF Stock 12 Month Forecast
Average Price Target
$67.71
▲(32.86% Upside)
Technical Analysis
Best Analysts Covering CAMRF
1 Year
1 Year Success Rate
1/3 ratings generated profit
1 Year Average Return
+32.53%
reiterated a buy rating 2 months ago
Copying Brian Balchin's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of +32.53% per trade.
---